JP2005528154A - 無酸素的茶煎出器具及びその使用法 - Google Patents
無酸素的茶煎出器具及びその使用法 Download PDFInfo
- Publication number
- JP2005528154A JP2005528154A JP2004508630A JP2004508630A JP2005528154A JP 2005528154 A JP2005528154 A JP 2005528154A JP 2004508630 A JP2004508630 A JP 2004508630A JP 2004508630 A JP2004508630 A JP 2004508630A JP 2005528154 A JP2005528154 A JP 2005528154A
- Authority
- JP
- Japan
- Prior art keywords
- container
- water
- tea
- lid
- tea leaves
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims description 61
- 241001122767 Theaceae Species 0.000 title abstract 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 174
- 239000000284 extract Substances 0.000 claims abstract description 38
- 244000269722 Thea sinensis Species 0.000 claims description 240
- 235000013616 tea Nutrition 0.000 claims description 221
- 235000009569 green tea Nutrition 0.000 claims description 35
- 239000000463 material Substances 0.000 claims description 35
- 235000019645 odor Nutrition 0.000 claims description 19
- 229910052573 porcelain Inorganic materials 0.000 claims description 15
- 239000011521 glass Substances 0.000 claims description 12
- 239000004033 plastic Substances 0.000 claims description 11
- 229920003023 plastic Polymers 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 10
- 239000002184 metal Substances 0.000 claims description 10
- 230000035622 drinking Effects 0.000 claims description 9
- 239000004615 ingredient Substances 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 7
- 229910052571 earthenware Inorganic materials 0.000 claims description 6
- 238000011049 filling Methods 0.000 claims description 6
- 239000000919 ceramic Substances 0.000 claims description 5
- 238000004140 cleaning Methods 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 239000012634 fragment Substances 0.000 claims description 2
- 238000007599 discharging Methods 0.000 claims 1
- 239000003657 drainage water Substances 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 abstract description 11
- 235000006708 antioxidants Nutrition 0.000 abstract description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 11
- 239000001301 oxygen Substances 0.000 abstract description 11
- 229910052760 oxygen Inorganic materials 0.000 abstract description 11
- 230000003078 antioxidant effect Effects 0.000 abstract description 8
- 235000013361 beverage Nutrition 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract description 4
- 208000010772 Dog disease Diseases 0.000 abstract 1
- 230000006806 disease prevention Effects 0.000 abstract 1
- 238000010561 standard procedure Methods 0.000 abstract 1
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 24
- 150000003254 radicals Chemical class 0.000 description 19
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 17
- 241000282472 Canis lupus familiaris Species 0.000 description 15
- XMOCLSLCDHWDHP-IUODEOHRSA-N epi-Gallocatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-IUODEOHRSA-N 0.000 description 14
- 229940030275 epigallocatechin gallate Drugs 0.000 description 13
- 230000003647 oxidation Effects 0.000 description 12
- 238000007254 oxidation reaction Methods 0.000 description 12
- 230000008569 process Effects 0.000 description 12
- 206010025323 Lymphomas Diseases 0.000 description 11
- 235000020688 green tea extract Nutrition 0.000 description 11
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 10
- 206010028980 Neoplasm Diseases 0.000 description 10
- 239000007864 aqueous solution Substances 0.000 description 10
- 238000009835 boiling Methods 0.000 description 10
- 201000011510 cancer Diseases 0.000 description 10
- 229940094952 green tea extract Drugs 0.000 description 10
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 10
- 229960004618 prednisone Drugs 0.000 description 10
- 229910001882 dioxygen Inorganic materials 0.000 description 9
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 8
- 230000036541 health Effects 0.000 description 7
- 230000007407 health benefit Effects 0.000 description 7
- 230000002829 reductive effect Effects 0.000 description 7
- 238000011282 treatment Methods 0.000 description 7
- LSHVYAFMTMFKBA-TZIWHRDSSA-N (-)-epicatechin-3-O-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=CC=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-TZIWHRDSSA-N 0.000 description 6
- AOJJSUZBOXZQNB-TZSSRYMLSA-N Doxorubicin Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(=O)CO)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 AOJJSUZBOXZQNB-TZSSRYMLSA-N 0.000 description 6
- LSHVYAFMTMFKBA-UHFFFAOYSA-N ECG Natural products C=1C=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 LSHVYAFMTMFKBA-UHFFFAOYSA-N 0.000 description 6
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 6
- 235000005487 catechin Nutrition 0.000 description 6
- 238000000605 extraction Methods 0.000 description 6
- 150000008442 polyphenolic compounds Chemical class 0.000 description 6
- 235000013824 polyphenols Nutrition 0.000 description 6
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 5
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 5
- 240000003553 Leptospermum scoparium Species 0.000 description 5
- 235000015459 Lycium barbarum Nutrition 0.000 description 5
- 206010039897 Sedation Diseases 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 150000001765 catechin Chemical class 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 5
- 235000012734 epicatechin Nutrition 0.000 description 5
- 235000013305 food Nutrition 0.000 description 5
- 210000001165 lymph node Anatomy 0.000 description 5
- 230000036280 sedation Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 241000282465 Canis Species 0.000 description 4
- CMSMOCZEIVJLDB-UHFFFAOYSA-N Cyclophosphamide Chemical compound ClCCN(CCCl)P1(=O)NCCCO1 CMSMOCZEIVJLDB-UHFFFAOYSA-N 0.000 description 4
- 241000282412 Homo Species 0.000 description 4
- XMOCLSLCDHWDHP-UHFFFAOYSA-N L-Epigallocatechin Natural products OC1CC2=C(O)C=C(O)C=C2OC1C1=CC(O)=C(O)C(O)=C1 XMOCLSLCDHWDHP-UHFFFAOYSA-N 0.000 description 4
- 235000006468 Thea sinensis Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 229940044683 chemotherapy drug Drugs 0.000 description 4
- 229960004397 cyclophosphamide Drugs 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 238000000354 decomposition reaction Methods 0.000 description 4
- DZYNKLUGCOSVKS-UHFFFAOYSA-N epigallocatechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3cc(O)c(O)c(O)c3 DZYNKLUGCOSVKS-UHFFFAOYSA-N 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 125000004402 polyphenol group Chemical group 0.000 description 4
- 229930013783 (-)-epicatechin Natural products 0.000 description 3
- 235000007355 (-)-epicatechin Nutrition 0.000 description 3
- 229930014124 (-)-epigallocatechin gallate Natural products 0.000 description 3
- 235000004911 (-)-epigallocatechin gallate Nutrition 0.000 description 3
- 241001180747 Hottea Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002648 combination therapy Methods 0.000 description 3
- 229960004679 doxorubicin Drugs 0.000 description 3
- VFSWRBJYBQXUTE-UHFFFAOYSA-N epi-Gallocatechin 3-O-gallate Natural products Oc1ccc2C(=O)C(OC(=O)c3cc(O)c(O)c(O)c3)C(Oc2c1)c4cc(O)c(O)c(O)c4 VFSWRBJYBQXUTE-UHFFFAOYSA-N 0.000 description 3
- 238000006345 epimerization reaction Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- -1 iron ions Chemical class 0.000 description 3
- 208000032839 leukemia Diseases 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 102100025573 1-alkyl-2-acetylglycerophosphocholine esterase Human genes 0.000 description 2
- 108010024976 Asparaginase Proteins 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 206010010904 Convulsion Diseases 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 206010057190 Respiratory tract infections Diseases 0.000 description 2
- 206010074054 Trigeminal neuritis Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000012670 alkaline solution Substances 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000020279 black tea Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 125000004403 catechin group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 231100000433 cytotoxic Toxicity 0.000 description 2
- 230000001472 cytotoxic effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000001627 detrimental effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- YTAQZPGBTPDBPW-UHFFFAOYSA-N flavonoid group Chemical group O1C(C(C(=O)C2=CC=CC=C12)=O)C1=CC=CC=C1 YTAQZPGBTPDBPW-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002650 habitual effect Effects 0.000 description 2
- 230000009931 harmful effect Effects 0.000 description 2
- 210000005260 human cell Anatomy 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 230000001590 oxidative effect Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OGWKCGZFUXNPDA-XQKSVPLYSA-N vincristine Chemical compound C([N@]1C[C@@H](C[C@]2(C(=O)OC)C=3C(=CC4=C([C@]56[C@H]([C@@]([C@H](OC(C)=O)[C@]7(CC)C=CCN([C@H]67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)C[C@@](C1)(O)CC)CC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-XQKSVPLYSA-N 0.000 description 2
- 229960004528 vincristine Drugs 0.000 description 2
- OGWKCGZFUXNPDA-UHFFFAOYSA-N vincristine Natural products C1C(CC)(O)CC(CC2(C(=O)OC)C=3C(=CC4=C(C56C(C(C(OC(C)=O)C7(CC)C=CCN(C67)CC5)(O)C(=O)OC)N4C=O)C=3)OC)CN1CCC1=C2NC2=CC=CC=C12 OGWKCGZFUXNPDA-UHFFFAOYSA-N 0.000 description 2
- WMBWREPUVVBILR-NQIIRXRSSA-N (-)-gallocatechin gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-NQIIRXRSSA-N 0.000 description 1
- MGWGWNFMUOTEHG-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)-1,3-thiazol-2-amine Chemical compound CC1=CC(C)=CC(C=2N=C(N)SC=2)=C1 MGWGWNFMUOTEHG-UHFFFAOYSA-N 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 241000699800 Cricetinae Species 0.000 description 1
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013642 Drooling Diseases 0.000 description 1
- 206010061825 Duodenal neoplasm Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 208000008771 Lymphadenopathy Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 208000000453 Skin Neoplasms Diseases 0.000 description 1
- 206010054184 Small intestine carcinoma Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000000809 air pollutant Substances 0.000 description 1
- 231100001243 air pollutant Toxicity 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000000578 anorexic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000003850 cellular structure Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 238000009096 combination chemotherapy Methods 0.000 description 1
- 229910001431 copper ion Inorganic materials 0.000 description 1
- 229940127089 cytotoxic agent Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 201000000312 duodenum cancer Diseases 0.000 description 1
- 201000004101 esophageal cancer Diseases 0.000 description 1
- 238000007387 excisional biopsy Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000002920 hazardous waste Substances 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 208000018555 lymphatic system disease Diseases 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Inorganic materials O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 201000002528 pancreatic cancer Diseases 0.000 description 1
- 208000008443 pancreatic carcinoma Diseases 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 201000000849 skin cancer Diseases 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000011301 standard therapy Methods 0.000 description 1
- 238000011272 standard treatment Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 238000009121 systemic therapy Methods 0.000 description 1
- 238000011285 therapeutic regimen Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A47—FURNITURE; DOMESTIC ARTICLES OR APPLIANCES; COFFEE MILLS; SPICE MILLS; SUCTION CLEANERS IN GENERAL
- A47J—KITCHEN EQUIPMENT; COFFEE MILLS; SPICE MILLS; APPARATUS FOR MAKING BEVERAGES
- A47J31/00—Apparatus for making beverages
- A47J31/002—Apparatus for making beverages following a specific operational sequence, e.g. for improving the taste of the extraction product
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/16—Tea extraction; Tea extracts; Treating tea extract; Making instant tea
- A23F3/18—Extraction of water soluble tea constituents
Landscapes
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Tea And Coffee (AREA)
- Medicines Containing Plant Substances (AREA)
- Table Devices Or Equipment (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/161,325 US6821541B2 (en) | 2002-06-03 | 2002-06-03 | Anaerobic tea steeper and method of use |
PCT/US2003/016843 WO2003101263A1 (fr) | 2002-06-03 | 2003-05-29 | Recipient pour infusion de the anaerobie et son procede d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2005528154A true JP2005528154A (ja) | 2005-09-22 |
Family
ID=29583404
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004508630A Pending JP2005528154A (ja) | 2002-06-03 | 2003-05-29 | 無酸素的茶煎出器具及びその使用法 |
Country Status (8)
Country | Link |
---|---|
US (2) | US6821541B2 (fr) |
EP (1) | EP1509111A4 (fr) |
JP (1) | JP2005528154A (fr) |
CN (1) | CN1658780A (fr) |
AU (1) | AU2003245348A1 (fr) |
CA (1) | CA2485946A1 (fr) |
RU (1) | RU2004139105A (fr) |
WO (1) | WO2003101263A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014506827A (ja) * | 2011-03-04 | 2014-03-20 | タケヤ・ユーエスエー・コーポレーション | 飲料を抽出および冷却する方法およびシステム |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4135061B2 (ja) * | 2002-01-31 | 2008-08-20 | 東洋製罐株式会社 | 容器入り焙煎飲料の製造方法 |
FI115753B (fi) * | 2002-11-29 | 2005-07-15 | Paloheimo Raija | Menetelmä ja sovitelma kahvijuomien valmistamiseksi |
WO2007027206A2 (fr) | 2005-04-11 | 2007-03-08 | Coffee Equipment Company | Machine pour infuser une boisson comme du café et procédé s'y rapportant |
RU2387360C2 (ru) | 2005-04-11 | 2010-04-27 | Старбакс Корпорейшн | Машина и способ для приготовления напитка, такого как кофе |
US20080097249A1 (en) * | 2006-10-20 | 2008-04-24 | Ellipse Technologies, Inc. | External sensing system for gastric restriction devices |
US20080160135A1 (en) * | 2006-12-27 | 2008-07-03 | Conopco, Inc., D/B/A Unilever | Method for Making a Tea Extract and a Tea Extract |
US20080216664A1 (en) * | 2007-03-09 | 2008-09-11 | Taylor Precision Products, Inc. | Electronic tea thermometer and timer device |
US20090246344A1 (en) * | 2008-03-31 | 2009-10-01 | Sasaki Tea Manufacturing Co., Ltd. | Antioxidant Agent and Beverage Using Same |
IT1393999B1 (it) * | 2009-04-01 | 2012-05-17 | Rancilio Macchine Caffe | Macchina per la preparazione di infusi, in particolare caffe' espresso, gruppo erogatore e metodo di realizzazione della stessa |
US20110056386A1 (en) * | 2009-09-10 | 2011-03-10 | Hiroshi Taketani | Pitcher with infuser |
USD713672S1 (en) | 2013-05-09 | 2014-09-23 | Takeya Usa Corporation | Pitcher top |
USD735514S1 (en) | 2014-02-10 | 2015-08-04 | Takeya Usa Corporation | Portable brewing device |
USD750426S1 (en) | 2014-04-23 | 2016-03-01 | Takeya Usa Corporation | Pitcher |
CN105078133A (zh) * | 2015-06-18 | 2015-11-25 | 昆山羽日电子科技有限公司 | 一种不锈钢保温杯铝箔内胆结构及其制作工艺 |
US10729273B1 (en) * | 2016-01-05 | 2020-08-04 | Bona Fide Brewing Company, LLC | Method and system for producing and packaging brewed beverage products |
RU2754461C1 (ru) | 2016-11-09 | 2021-09-02 | Пепсико, Инк. | Устройства, способы и системы для приготовления газированных напитков |
CN112273961A (zh) * | 2020-10-20 | 2021-01-29 | 刘廷佑 | 一种具有自动开合功能的茶壶 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US388274A (en) * | 1888-08-21 | Mail-bag catcher | ||
US1777909A (en) * | 1930-10-07 | Herbert leslie brookes | ||
US313144A (en) * | 1885-03-03 | Sweep-coupling for grinding-m i lls | ||
US673371A (en) * | 1899-12-16 | 1901-04-30 | W A Buchanan | Steeper. |
US1596415A (en) * | 1925-10-01 | 1926-08-17 | Stephen P Enright | Coffee and tea pot |
US1722696A (en) * | 1927-07-12 | 1929-07-30 | William Edward Ballard | Teapot |
US2835188A (en) * | 1955-04-27 | 1958-05-20 | Maurice W Graham | Automatic tea maker |
US3063359A (en) * | 1957-12-17 | 1962-11-13 | David O Brant | Coffee maker |
US4309940A (en) * | 1976-12-22 | 1982-01-12 | Lowerre Jr William M | Infusion type beverage maker |
JPS58165738A (ja) * | 1982-03-29 | 1983-09-30 | Keitaro Ashikawa | 褐変茶およびその製造方法 |
USD313144S (en) | 1987-05-25 | 1990-12-25 | Rowenta-Werke Gmbh | Teamaker |
DK17691A (da) * | 1991-02-01 | 1991-09-11 | Pi Design Ag | Filterindsats til beholdere |
US5478586A (en) * | 1994-08-16 | 1995-12-26 | Connor; Linda | Coffee, tea or beverage maker |
US5531353A (en) * | 1994-10-26 | 1996-07-02 | Ward; Ronald K. | Drinking cup device |
US5687637A (en) * | 1995-04-28 | 1997-11-18 | Healthometer, Inc. | Automatic tea brewing device |
USD388274S (en) | 1996-10-08 | 1997-12-30 | Chih-Hung Wang | Tea brewing container |
CA2331488A1 (fr) * | 1998-05-12 | 1999-11-18 | Windmill Holdings Limited | Appareil a faire des boissons |
US6299925B1 (en) | 1999-06-29 | 2001-10-09 | Xel Herbaceuticals, Inc. | Effervescent green tea extract formulation |
GB2354696B (en) * | 1999-09-28 | 2001-10-31 | Chuan Jang Yeh | Support for beverage making device |
US6264995B1 (en) * | 1999-10-19 | 2001-07-24 | Thomas Newmark | Herbal composition for reducing inflammation and methods of using same |
USD450522S1 (en) * | 2000-04-11 | 2001-11-20 | Jason C. S. Chen | Chinese tea brewing system |
AU144169S (en) * | 2000-05-10 | 2001-06-07 | Pi Design Ag | A kettle |
USD444337S1 (en) * | 2001-01-26 | 2001-07-03 | Parkersburg Road Corp. | Teakettle |
-
2002
- 2002-06-03 US US10/161,325 patent/US6821541B2/en not_active Expired - Fee Related
-
2003
- 2003-05-29 CN CN03812825XA patent/CN1658780A/zh active Pending
- 2003-05-29 JP JP2004508630A patent/JP2005528154A/ja active Pending
- 2003-05-29 EP EP03738987A patent/EP1509111A4/fr not_active Withdrawn
- 2003-05-29 AU AU2003245348A patent/AU2003245348A1/en not_active Abandoned
- 2003-05-29 CA CA002485946A patent/CA2485946A1/fr not_active Abandoned
- 2003-05-29 RU RU2004139105/12A patent/RU2004139105A/ru not_active Application Discontinuation
- 2003-05-29 WO PCT/US2003/016843 patent/WO2003101263A1/fr active Application Filing
-
2004
- 2004-07-15 US US10/891,809 patent/US20040261631A1/en not_active Abandoned
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2014506827A (ja) * | 2011-03-04 | 2014-03-20 | タケヤ・ユーエスエー・コーポレーション | 飲料を抽出および冷却する方法およびシステム |
Also Published As
Publication number | Publication date |
---|---|
WO2003101263A1 (fr) | 2003-12-11 |
AU2003245348A1 (en) | 2003-12-19 |
CA2485946A1 (fr) | 2003-12-11 |
CN1658780A (zh) | 2005-08-24 |
US6821541B2 (en) | 2004-11-23 |
RU2004139105A (ru) | 2005-07-10 |
EP1509111A4 (fr) | 2007-06-27 |
EP1509111A1 (fr) | 2005-03-02 |
US20030221563A1 (en) | 2003-12-04 |
US20040261631A1 (en) | 2004-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6821541B2 (en) | Anaerobic tea steeper and method of use | |
Kuroda et al. | Health effects of tea and its catechins | |
Lee et al. | Flavors of green tea change little during storage | |
TWI666989B (zh) | 咖啡生豆的加工方法 | |
KR100800241B1 (ko) | 기능성 커피, 그의 제조방법 및 이의 포장방법 | |
CN100425687C (zh) | 一种咖啡奶酒的配制方法 | |
CN105876029A (zh) | 铁皮石斛复方饮品及其制备方法 | |
JP4514210B2 (ja) | 甜茶飲料 | |
KR20090088122A (ko) | 산약 차 제조방법 | |
KR100565414B1 (ko) | 음용이 용이한 구절초 액상 조성물 | |
CN102144702B (zh) | 一种袋泡养肝茶 | |
JP3198425U (ja) | 飲料用食器 | |
KR20060100300A (ko) | 녹차가 첨가된 음료 | |
CN107280368A (zh) | 一种分区茶壶 | |
RU2259054C1 (ru) | Пособ приготовления чая | |
KR101069855B1 (ko) | 미나리를 포함하는 숙취해소용 음료 및 그의 제조방법 | |
Dow | The healing power of tea: simple teas & tisanes to remedy and rejuvenate your health | |
CN208510536U (zh) | 一种分区茶壶 | |
EP2556776A1 (fr) | Procédé pour la préparation de perfusions | |
van Driem | The tale of tea | |
Antol | Healing Teas: A Practical Guide to the Medicinal Teas of the World--from Chamomile to Garlic, from Essiac to Kombucha | |
CN114287488A (zh) | 一种柚子茶及其制作方法 | |
KR20230013326A (ko) | 블렌딩 차 제조 방법 및 이에 의해 제조된 블렌딩 차 | |
WO2006073356A1 (fr) | Produit pour administration de la cafeine dans la cavite buccale | |
CN107513483A (zh) | 一种泡制野生蔷薇果酒的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060410 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20080430 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20081007 |